STAAR Surgical (STAA) Misses Q4 EPS by 1c, provides guidance

STAAR Surgical (NASDAQ: STAA) reported Q4 EPS of $0.16, $0.01 worse than the analyst estimate of $0.17. Revenue for the quarter came in at $76.3 million versus the consensus estimate of $75.94 million.

GUIDANCE:

STAAR Surgical sees FY2024 revenue of $335-340 million, versus the consensus of $337.7 million. Adjusted EBITDA of approximately $36 million and Adjusted EBITDA per diluted share of approximately $0.70.2

For earnings history and earnings-related data on STAAR Surgical (STAA) click here.

You May Also Be Interested In

• Bernstein sees downside risk to Apple's December quarter results
• H.B. Fuller (FUL) Tops Q3 EPS by 5c, Misses on Revenue; Offers FY26 EPS Guidance
• Cracker Barrel (CBRL) Tops Q4 EPS by 89c, Offers Guidance